GHERARDI, ERMANNO
 Distribuzione geografica
Continente #
NA - Nord America 2.912
AS - Asia 2.290
EU - Europa 1.718
SA - Sud America 273
AF - Africa 117
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.317
Nazione #
US - Stati Uniti d'America 2.861
CN - Cina 1.162
SG - Singapore 499
IE - Irlanda 372
UA - Ucraina 279
BR - Brasile 213
HK - Hong Kong 213
VN - Vietnam 201
DE - Germania 181
RU - Federazione Russa 173
FI - Finlandia 166
SE - Svezia 134
IT - Italia 118
GB - Regno Unito 113
FR - Francia 108
ZA - Sudafrica 88
IN - India 56
BD - Bangladesh 30
CA - Canada 24
IQ - Iraq 23
JP - Giappone 23
AR - Argentina 22
BE - Belgio 16
ID - Indonesia 16
MX - Messico 13
NL - Olanda 12
CO - Colombia 11
ES - Italia 11
PK - Pakistan 10
SA - Arabia Saudita 9
AT - Austria 8
TR - Turchia 8
EC - Ecuador 7
KE - Kenya 7
PL - Polonia 7
UZ - Uzbekistan 6
VE - Venezuela 6
CL - Cile 5
CR - Costa Rica 5
LT - Lituania 5
BO - Bolivia 4
ET - Etiopia 4
JO - Giordania 4
NP - Nepal 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
KG - Kirghizistan 3
PY - Paraguay 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
CZ - Repubblica Ceca 2
EU - Europa 2
KR - Corea 2
LU - Lussemburgo 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
TT - Trinidad e Tobago 2
BF - Burkina Faso 1
BH - Bahrain 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
UY - Uruguay 1
Totale 7.317
Città #
Chandler 512
Dublin 370
Jacksonville 308
Nanjing 292
Singapore 269
San Jose 257
Ashburn 244
Hong Kong 212
Beijing 163
Boardman 127
Dallas 126
Nanchang 109
Johannesburg 82
Princeton 79
Lawrence 78
Wilmington 77
Hebei 75
Ann Arbor 74
Shenyang 73
Lauterbourg 68
Changsha 66
Ho Chi Minh City 62
Los Angeles 61
Medford 52
Jiaxing 45
Buffalo 44
Hanoi 42
Moscow 42
Tianjin 42
Milan 35
Hangzhou 30
New York 28
Council Bluffs 27
Munich 27
Helsinki 26
São Paulo 25
Shanghai 24
Woodbridge 22
Norwalk 21
Orem 20
Santa Clara 20
Verona 20
Pavia 19
Tokyo 18
Chennai 17
Brussels 16
Da Nang 14
Frankfurt am Main 14
Haiphong 14
Rio de Janeiro 12
Seattle 12
Baghdad 11
Kunming 11
Montreal 11
Phoenix 11
Zhengzhou 10
Guangzhou 9
San Francisco 9
Amsterdam 8
Atlanta 7
Biên Hòa 7
Falls Church 7
Nuremberg 7
Redondo Beach 7
Warsaw 7
Brooklyn 6
Denver 6
Jinan 6
London 6
Shenzhen 6
Toronto 6
Boston 5
Brasília 5
Chicago 5
Fairfield 5
Manchester 5
Mumbai 5
Nairobi 5
Poplar 5
Pune 5
San José 5
Tashkent 5
The Dalles 5
Washington 5
Addis Ababa 4
Amman 4
Auburn Hills 4
Bengaluru 4
Cairo 4
Curitiba 4
Des Moines 4
Medellín 4
New Delhi 4
Recife 4
Riyadh 4
Stockholm 4
Taizhou 4
Vienna 4
Athens 3
Belo Horizonte 3
Totale 4.797
Nome #
Maturazione dell’affinità anticorpale nel sistema del 2-fenil-5-ossazolone 136
Aromatic amino acids at the surface of InlB are essential for host cell invasion by Listeria monocytogenes. 135
A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping. 135
Characterisation of the SF/HGF gene promoter. 134
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. 127
Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein. 126
Co-expression of the HGF/SF and c-met genes during early mouse embryongenesis precedes reciprocal expression in adjacent tissues during organogenesis 126
A role of HGF/SF in neural induction and its expression in Hensen's node during gastrulation. 123
Met receptor agonist proteins 122
Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit 121
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. 120
A G2/M cell cycle block in transformed cells by contact with normal neighbors. 120
A novel HGF/SF receptor (MET) agonist transiently delays the disease progression in an amyotrophic lateral sclerosis mouse model by promoting neuronal survival and dampening the immune dysregulation 119
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain 117
Structural basis of hepatocyte growth factor/scatter factor and MET signalling. 115
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. 114
Affinity Maturation of Antibodies in the 2-Phenyl-5-Oxazolone System 113
Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis 113
Ingegneria degli anticorpi 112
Structural Basis of Affinity Maturation of Antibodies in the 2- Phenyl-5-Oxazolone System 111
A Mechanistic Basis for Converting a Growth-Factor Receptor Agonist to an Antagonist. 110
Multimeric compounds of a kringle domain from the hepatocyte growth factor / scatter factor (hgf/sf) 109
Crystal structure of an engineered YopM-InlB hybrid protein 108
A Novel Multipurpose Monoclonal Antibody for Evaluating Human c-Met Expression in Preclinical and Clinical Settings 106
Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells. 105
Roles of Hepatocyte Growth Factor/Scatter Factor and the Met Receptor in the Early Development of the Metanephros. 104
Computer-assisted mass spectrometric analysis of naturally occurring and artificially introduced cross-links in proteins and protein complexes. 104
Epithelial scatter factor and development of the chick embryonic axis. 103
Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis. 101
X-ray and neutron small-angle scattering analysis of the complex formed by the Met receptor and the Listeria monocytogenes invasion protein InlB 100
Developing antagonists for the Met-HGF/SF protein-protein interaction using a fragment-based approach 100
Structural basis of affinity maturation of the TEPC15/Vkappa 45.1 anti-2-phenyl-5-oxazolone antibodies. 97
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans and improved activity in vivo. 97
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. 96
Inhibition of the MET Kinase Activity and Cell Growth in MET-Addicted Cancer Cells by Bi-Paratopic Linking 96
Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. 95
Ingegnerizzazione di mAb per scopi teraupeutici 95
The sema domain. 94
Met, metastasis, motility and more. 94
Generation and characterization of novel recombinant antihERG1 scFv antibodies for cancer molecular imaging 92
Heparan sulphate-modified CD44 promotes hepatocyte grwoth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met 89
Mutation and selection during the secondary response to 2-phenyloxazolone. 89
The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans. 89
Isolation of high affinity human antibodies directly from large synthetic repertoires. 88
Maturazione dell’affinità anticorpale 87
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. 86
Non-random features of the repertoire expressed by the members of one Vk gene family and V-J recombination. 86
Scatter factor is a fibroblast-derived modulator of epithelial cell motility. 84
One man and his molecule 84
Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist 83
Scatter factor/hepatocyte growth factor is essential for liver development. 83
Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells 82
The effect of high-frequency random mutagenesis on in vitro protein evolution: a stuudy on TEM-1 beta-lactamase. 82
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. 81
HGF/SF inhibits junctional communication. 80
Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB 78
Original and artificial antibodies. 77
The structural repertoire of the human Vk domain. 76
Targeting MET in cancer: rationale and progress 76
Expression of a Cx43 deletion mutant in 3T3 A31 fibroblasts prevents PDGF-induced inhibition of cell communication and suppresses cell growth 75
Structural Basis of Affinity Maturation of Antibodies in the 2-Phenyl-5-Oxazolone System 73
Ligand-Mediated Dimerization of the Met Receptor Tyrosine Kinase by the Bacterial Invasion Protein InlB 73
Protein Engineered Variants of Hepatocyte Growth Factor/Scatter Factor Promote Proliferation of Primary Human Hepatocytes and in Rodent Liver 73
Down regulation of scatter factor in MRC 5 fibroblasts by epithelial-derived cells. A model for scatter factor modulation. 73
Diverse and potent activities of HGF/SF in skin wound repair. 73
Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding 70
Structural Basis of Affinity Maturation of Antibodies in the 2-Phenyl-5-Oxazolone System 70
Interactions of hepatocyte growth factor / scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. 70
MODIFIED HGF-1K1 POLYPEPTIDE. 69
Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET 69
Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. 69
Insights into the structure/function of HGF/SF from studies with individual domains. 68
Michael Stoker 1918–2013 66
Structural basis for agonism and antagonism of hepatocyte growth factor 63
Glycoprotein production for structure analysis with stable, glycosylation mutant CHO cell lines established by fluorescence-activated cell sorting 61
Erratum: Targeting MET in cancer: Rationale and progress (Nature Reviews Cancer (2012) 12 (89-103)) 59
Engineering the NK1 fragment of HGF/SF as a MET receptor antagonist. 56
Engineered variants of InlB with an additional leucine-rich repeat discriminate between physiologically relevant and packing contacts in crystal structures of the InlB:MET complex 52
Hepatocyte growth factor/scatter factor (HGF/SF) accelerates angiogenesis in sponge implants in mice: Modulation by L- name and NS 398 44
Totale 7.351
Categoria #
all - tutte 28.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022342 6 3 5 3 10 14 12 29 21 10 49 180
2022/20231.271 125 88 41 147 142 127 0 73 482 8 17 21
2023/2024320 38 55 18 21 43 69 9 38 2 8 10 9
2024/2025903 11 91 27 44 11 40 13 61 229 26 93 257
2025/20262.327 183 164 234 255 259 149 458 144 179 175 74 53
Totale 7.351